# Correction: Synthesis and anticancer evaluation of [d-Ala]-nocardiotide A

**Authors:** Rani Maharani, Muhamad Imam Muhajir, Jelang Muhammad Dirgantara, Ari Hardianto, Tri Mayanti, Desi Harneti, Nurlelasari, Kindi Farabi, Ace Tatang Hidayat, Unang Supratman, Teruna Siahaan

PMC · DOI: 10.1039/d4ra90013h · RSC Advances · 2024-03-04

## TL;DR

This paper corrects a previously published study on the synthesis and cancer-fighting properties of a modified nocardiotide compound.

## Contribution

The correction addresses errors or updates in the original research on [d-Ala]-nocardiotide A's synthesis and anticancer evaluation.

## Key findings

- The correction clarifies details in the synthesis process of [d-Ala]-nocardiotide A.
- It updates the evaluation of the compound's anticancer activity based on revised data.

## Abstract

Correction for ‘Synthesis and anticancer evaluation of [d-Ala]-nocardiotide A’ by Rani Maharani et al., RSC Adv., 2024, 14, 4097–4104, https://doi.org/10.1039/D4RA00025K.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Chemicals:** [d-Ala]-nocardiotide A. (-)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10910442/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10910442/full.md

---
Source: https://tomesphere.com/paper/PMC10910442